OPTIMA is an Innovative Medicines Initiative (IMI) project that is using artificial intelligence (AI) to improve care for patients with lung, prostate and breast cancer, which ELF is proud to be a part of. OPTIMA would like patients and patient representatives to help them decide on the most important research priorities in lung cancer and breast cancer.

After consulting with healthcare professionals and patients, OPTIMA have created two surveys: one for lung cancer (20 minutes) and one for breast cancer (30 minutes). They want patients to tell them how important each research topic is. For example, one possible research area is to determine how many people worldwide get lung cancer. Patients can say if this is critically important, not important at all, or somewhere in between.

The surveys are available in English, French, German, Italian and Spanish.

Lung cancer survey

Breast cancer survey

The deadline to complete the surveys is Tuesday 31 October.